Skip to content
MarketScale
‹ Back to IndustriesHealthcare

What’s Ahead for Hospital Purchased Services Cost Reduction Technology in 2018

Purchased services represents up to 45% of the non-labor expense budget within a health system. As more executives look to purchased services categories for potential expense reduction, 2018 is an important year, and Valify has several important innovations planned to assist clients in controlling and reducing purchased services expense in the year ahead: Major Initiatives…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Purchased services represents up to 45% of the non-labor expense budget within a health system. As more executives look to purchased services categories for potential expense reduction, 2018 is an important year, and Valify has several important innovations planned to assist clients in controlling and reducing purchased services expense in the year ahead:

Major Initiatives for the First Quarter of 2018

  • Social Network: Valify’s Expert Network draws on the power of community. “We are building a virtual space where clients can tap in to Valify’s community of users to share best practices, seek input from other members, and research specific vendors or categories,” explains Les Popiolek, Chief Operating Officer at Valify. (Launching to Valify customers March 2.)
  • Project Boards: Valify’s new Project Boards improve visibility of key purchased services led initiatives, keeping teams organized with real-time project status updates. It also allows users to quickly monitor savings initiatives by stage, campaign, owner, or strategy at a glance. (Launching to Valify customers March 2.)
  • Saving Project Tracker Enhancements: Valify’s Saving Project Tracker is an automated tool that monitors the spend and associated savings for a project. New enhancements in 2018 will allow for increased visibility and granularity in analyzing spend and realized savings. (Available to Valify customers March 2.)
  • Spend Alerts: Alerts for purchased service spending provides settings that can be personalized by each user. The automated performance tracking tool generates monthly notifications if vendor spend or project savings are not tracking as expected, eliminating the surprises that often occur after completing a big project. (Available to Valify customers March 2.)

More in Store for 2018

This year, customers can expect to be wow-ed yet again by an added depth of functionalities and increased level of automation within the Valify platform. Fine-tuning how data is visualized will not only highlight savings opportunities and auto-monitor spend, it will illuminate a path forward for realizing savings, and will isolate the root cause of spend spikes that are seen while monitoring so that corrective measures can be implemented.

In 2018, customers will have an even clearer lens over their spend data with options to create customizable views, and more comprehensive contract management functionality, creating better insights to help their teams contain purchased services expense.

What We’ve Achieved Together So Far

At Valify, we pride ourselves on maintaining close relationships with our clients. We balance soliciting feedback with offering guidance. Our customers appreciate their needs being heard and welcome new ideas through the expertise Valify provides.

Thanks to this partnership, Valify has continued to enhance the platform since the inception of our spend visibility technology bedrock. Most recently, we’ve added solutions that connect all pieces of the process to successfully and more easily achieve savings:

  • Sourcing Collaboration Suite (eRFP): Valify’s Sourcing Collaboration Suite streamlines subscribers’ daily processes, empowers better decision-making, and simplifies vendor management in one integrated platform. A module centered on creating and managing RFPs makes Valify’s intuitive technology tool even more useful.
  • Vendor Market Share: Vendor Market Share dovetails with our eRFP solution to illustrate which vendors are being hired by other organizations in a specific area for a given service. Market share clarity helps to increase vendor competition, and therefore, drive down overall costs.
  • Benchmarks Expansion: Deep category benchmarks are calculated using not only spend data, but also a wealth of operational metrics, including geographic considerations, frequency of utilization, unique category, and/or facility requirements, and other market conditions as well. Valify’s Benchmarks uses automated operational and efficiency analysts to identify exact areas where overspending is occurring by providing actionable data that can improve performance and decision support.

We look forward to another year of our clients’ continued success in realizing savings within purchased services.

Valify remains the industry’s most comprehensive solution 100% dedicated to managing purchased services expense. Our technology platform allows healthcare organizations to quickly identify, benchmark, and track savings across thousands of categories and suppliers. Adopting our proprietary benchmarking comparisons, organizations can apply monthly purchased services spend against hundreds of peer institutions to evaluate financial performance, prepare for vendor negotiations, and reduce costs that typically comprise up to 45% of a hospital’s non-labor budget.

Learn how to leverage Valify’s tools and strategies in your organization at http://www.getvalify.com/about-valify.

Read more at getvalify.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512